Brown Alan S, Watson Karol E
Division of Cardiology, Advocate Heart Institute at Advocate Lutheran General Hospital, Park Ridge, IL.
Departments of Medicine & Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Rev Cardiovasc Med. 2018;19(S1):S9-S19. doi: 10.3909/ricm19S1S0005.
Statins are critical medications to prevent and treat cardiovascular disease and they are generally very well tolerated. In some instances, however, statin intolerance may limit use of these lifesaving medications. Statin intolerance has many definitions but is commonly diagnosed when a patient is unable to continue statin therapy due to perceived, or objectively documented, adverse effects. A very high rate of discontinuation of statin therapy warrants a closer look at the implications from the standpoint of cardiovascular risk in statin-intolerant patients, as well as an evaluation of the available options to help patients maintain their statin therapy and understand the potential benefits of such therapy.
他汀类药物是预防和治疗心血管疾病的关键药物,并且通常耐受性良好。然而,在某些情况下,他汀类药物不耐受可能会限制这些救命药物的使用。他汀类药物不耐受有多种定义,但通常在患者因感觉到的或客观记录的不良反应而无法继续他汀类药物治疗时被诊断出来。他汀类药物治疗的停药率非常高,这就需要从他汀类药物不耐受患者的心血管风险角度更仔细地审视其影响,同时评估现有选项,以帮助患者维持他汀类药物治疗并了解这种治疗的潜在益处。